The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.00
Bid: 140.40
Ask: 141.00
Change: 0.00 (0.00%)
Spread: 0.60 (0.427%)
Open: 141.40
High: 142.00
Low: 140.40
Prev. Close: 141.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly results for 30 September 2021

4 Nov 2021 07:00

RNS Number : 2725R
Apax Global Alpha Limited
04 November 2021
 

(LSE: APAX)

 

 

 

Apax Global Alpha Limited

Quarterly results for the period ended 30 September 2021

 

 

Key highlights

 

Total NAV Return1 of 9.9% in the quarter (8.3% constant currency).

 

Total Adjusted NAV increased to c.1.5bn with Adjusted NAV per share, growing from €2.81 (£2.41) to €3.02 (£2.59) in the three months to 30 September 2021.

 

Performance in Private Equity driven primarily by earnings growth in the portfolio and an increase in multiples, mainly as a result of ThoughtWorks IPO in the quarter.

 

Private Equity exits achieved at healthy uplifts2 of 56.9%.

 

Strong investment pace in Private Equity, with AGA deploying c.€47m on a look through basis across three new Private Equity investments in the period.

 

Distributions of c.€85m received from Private Equity, including proceeds from one full exit (TietoEvry), one partial exit (Wizeline) and two public listings (ThoughtWorks and Paycor) in the period.

 

Five Derived Investments positions were realised in the quarter for a total of c. €70m, providing net realisations of c. €43m that can be used to meet future Private Equity calls.

 

Liquidity position is healthy with available cash after net liabilities of €73m, and the evergreen revolving credit facility of €140m remaining undrawn. Derived Investments of c.€394m3 provide a further source of funding for AGA.

 

Ralf Gruss, COO of Apax Partners, said:

 

"It has been another strong quarter and we are pleased to see that AGA's investment strategy and sector focus have continued to deliver robust NAV performance. In Private Equity, we have seen a number of transactions, primarily in the Tech sector. There continues to be a solid pipeline of deals and real momentum across the portfolio."

 

Financial highlights

 

· Growth in Adjusted NAV3 to c. €1.5 billion, up from c. €1.4 billion as at 30 June 2021.

· Portfolio weighted towards Private Equity (72%), vs. Derived Debt (24%) and Derived Equity (4%).

· AGA was 95% invested as at 30 September 2021 and had outstanding commitments to the Apax Funds (together with recallable distributions) of €434m. 

 

Q3 2021 (EUR)

Q3 2021 (GBP)

Adjusted NAV3

EUR 1,483m

GBP 1,274m

Adjusted NAV3 per share

EUR 3.02

GBP 2.59

NAV3 per share

EUR 3.03

GBP 2.61

 

Exposure

Q3 2021

Q3 2021constant currency

Total NAV Return1

9.9%

8.3%

Total Return1 - Private Equity

68%

13.6%

11.8%

Total Return1 - Derived Debt

23%

3.4%

1.5%

Total Return1 - Derived Equity

4%

6.5%

5.4%

Cash & Others

5%

 

 

 

 

Private Equity portfolio highlights

 

The Private Equity portfolio performed strongly in the quarter: Total Return1 of 13.6% (11.8% constant currency).

 

Deal activity reflective of Apax's 'good to great' investment strategy and sub-sector expertise, focusing on companies where a significant re-rating opportunity exists based on business quality improvement.

 

Aggregate Gross IRR4 and Gross MOIC4 on Private Equity exits in Q3 2021 were 73.6% and 6.5x respectively. Exits were achieved at an average uplift2 of 56.9%, reflecting the quality of the portfolio.

 

On a look-through basis, AGA invested c.€47m5 in three new investments in Tech that closed during the period.

 

Continued strong earnings growth and operating performance from the portfolio companies: LTM Revenue6 and EBITDA growth6 of 22% and 41% respectively across the Private Equity portfolio.

 

LTM Enterprise Value/EBITDA valuations multiples increased to 23.5x from 18.0x in June 2021, primarily driven by the re-rating of ThoughtWorks achieved at IPO.

 

The Apax Digital Fund II, to which AGA has made a commitment of $90m, closed at its $1.75bn hard cap in the period.

 

 

Derived Investments portfolio highlights

 

Steady performance across the portfolio with Derived Investments achieving a Total Return1 of 3.8% (2.0% constant currency) in the quarter, driven by Derived Debt which makes up 87% of the Derived Investments portfolio.

 

Continued focus on investments in lower risk first and second lien loans where there is a high degree of visibility on cash flow, and in target sub-sectors where Apax has unique insights gained from the Private Equity investment activity - c.€27m deployed across 4 new debt positions in Q3 2021.

Five Derived Investments positions were realised during the quarter with net distributions of c. €43m. The realisations reflect AGA's strategy of creating liquidity from the Derived Investments portfolio to support capital calls from the Apax Private Equity funds.

 

Strong operating performance from underlying Derived Debt portfolio companies: c.33% LTM EBITDA growth to 30 September 2021.

 

Reflecting the increased share of first lien loans and the impact of lower base rates in the portfolio, the overall yield to maturity of the portfolio stands at 6.5% at 30 September 2021.

 

No new investments in Derived Equity.

 

Derived Debt delivered a Total Return1 of 3.4% (1.5% constant currency) and Derived Equity delivered Total Return1 of 6.5% (5.4% constant currency) in the quarter.

 

 

For further information regarding the announcement of AGA's 2021 third quarter results, including the Company's results presentation and dial-in details for today's analyst and investor webcast at 9.30am (UK time), please visit www.apaxglobalalpha.com.

 

 

Contact details

Katarina Sallerfors

Investor Relations - AGA

 

Telephone: +44 (0)207 666 6526

 

Email: katarina.sallerfors@apax.com

 

 

 

 

APPENDIX

 

Movements in NAV

 

Adjusted NAV3 movements (€m)

Private Equity

Derived Investments

Cash

Treasury Shares

Facility drawn

Other

Q3 2021 Total

Adjusted NAV at 30.6.21

916.6

434.7

78.4

-

-

(49.4)

1,380.3

+ Investments

59.2

27.1

(122.1)

-

-

35.8

-

- Distributions/ divestments

(84.8)

(70.2)

154.7

-

-

0.3

-

+ Interest and dividend income

-

-

11.8

-

-

0.6

12.4

+/- Gains/(losses)

108.9

(2.8)

-

-

-

-

106.1

+/- FX gains/(losses)7

16.2

7.0

(0.4)

-

-

-

22.8

+/- Costs and other movements

-

-

(2.2)

-

-

0.1

(2.1)

 - Dividends paid

-

-

(34.4)

-

-

-

(34.4)

+/- Performance fee reserve

-

(2.1)

-

-

-

-

(2.1)

+/- Treasury shares

-

-

-

-

-

-

-

+/- Revolving credit facility

drawn/repaid

-

-

-

-

-

-

-

Adjusted NAV at 30.9.213

1,016.1

393.7

85.8

-

-

(12.6)

1,483.0

 

Private Equity - operational metrics

 

Private Equity - operational metrics

30 September 2021

30 June 2021

Portfolio year-over-year LTM revenue growth6

21.5%

22.3%

Portfolio year-over-year LTM EBITDA growth6

41.0%

42.7%

Enterprise Value / EBITDA valuation multiple6

23.5x

18.0x

Net debt / EBITDA multiple6

3.4x

3.7x

 

 

Derived Investments - operational metrics

 

Derived Investments - operational metrics

30 September 2021

30 June 2021

Debt year-over-year LTM EBITDA growth8

32.6%

37.3%

Debt average income yield to maturity8

6.5%

6.8%

Debt average years to maturity

6.2

5.9

Debt average income yield9

6.5%

6.4%

 

 

Other Invested Portfolio highlights

 

Invested Portfolio analysis10

€m

€m

%

%

- AMI

52.5

4%

- AEVI

7.3

0%

- AEVII

23.4

2%

- AVIII

164.8

11%

- AIX

576.4

41%

- ADF

38.3

3%

- AX

153.4

11%

Private Equity

1,016.1

72%

- Derived Debt

348.8

24%

- Derived Equity

51.5

4%

Derived Investments

400.3

28%

Total

1,416.4

100%

 

 

 

 

 

 

 

 

 

Footnotes

1.

"Total NAV Return" means the movement in the Adjusted NAV per share over the period plus any dividends paid. "Total Return" reflects the sub-portfolio performance on a stand-alone basis. It excludes items at the overall AGA level such as cash, management fees, and costs

2.

Valuation uplifts on exits are calculated based on the total actual or estimated sales proceeds and income as appropriate since the last Unaffected Valuation. Unaffected Valuation is determined as the fair value in the last quarter before exit, when valuation is not affected by the exit process (i.e. because an exit was signed, or an exit was sufficiently close to being signed that the Apax Funds incorporated the expected exit multiple into the quarter end valuation). Average uplift of full exits and significant partial exits in the current period calculated based on the expected sales proceeds and/ or the fair value remaining. For investments where there were subsequent partial realisations since June 2021, uplift calculated by taking proceeds received in Q3 2021 plus remaining fair value at 30 September 2021 compared to fair value at 30 June 2021

3.

NAV was €1,489.6m whilst Adjusted NAV was €1,483.0m reflecting the estimated performance fee reserve of €6.6m at period end. Private Equity NAV and Adjusted NAV were the same at €1,016.1m. Derived Investments NAV was €400.3m compared to an Adjusted NAV of €393.7m which has an adjustment of €6.6m for the performance fee reserve.

4.

Private Equity Aggregate Gross IRR and Gross MOIC, combined in EUR, of 73.6% and 6.5x calculated based on the aggregate cash flows across all funds for the 1 full exit, 1 partial exit and 2 IPOs

5.

€47m of invested cost in new Private Equity investments remains subject to final closing adjustments

6.

Gross Asset Value weighted average of the respective metric across the portfolio. At June 2021 and September 2021, 21 and 24 investments were excluded (investments in the financial services sector; companies with negative EBITDA or moving from negative to positive EBITDA; investments that are written-off; companies where EBITDA is not meaningful for specific reasons)

7.

FX on cash includes the revaluation of cash balances and net losses arising from the differences in exchange rates between transaction dates and settlement dates, and unrealised net losses arising from the translation into euro of assets and liabilities (other than investments) which are not denominated in euro

8.

Gross Asset Value weighted average of the respective metric across the Derived Debt portfolio

9.

Gross Asset Value weighted average of the current full year income (annual coupon/clean price as at the respective date) for each debt position in the Derived Debt portfolio as at the respective date

10.

Invested Portfolio excludes cash and cash equivalents, revolving credit facility drawn and net current assets, including these the NAV was €1,489.6m and Adjusted NAV was €1,483.0m reflecting adjustment of €6.6m for the estimated performance fee reserve

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax" or "the Investment Adviser"

 

2.

Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR")

 

3.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions

 

4.

The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States

 

5.

This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement.

 

 

 

 

 

 

 

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities.

 

Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax") is a leading global private equity advisory firm. For nearly 50 years, Apax has worked to inspire growth and ideas that transform businesses. The firm has raised and advised funds with aggregate commitments of more than $60 billion. The Apax Funds invest in companies across four global sectors of Tech, Services, Healthcare, and Internet/Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. For further information about Apax, please visit www.apax.com.

 

Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTEAXFDEAXFFFA
Date   Source Headline
24th Apr 20247:00 amRNSApax Funds to acquire IANS
18th Apr 20247:00 amRNSApax Funds To Acquire Zellis Group
5th Apr 20249:58 amRNSDirector/PDMR Shareholding
4th Apr 20242:02 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSNotice of Capital Markets Day
22nd Mar 202410:08 amRNSHolding in Company
11th Mar 20245:17 pmRNSPurchase of Ordinary Shares under IMA
5th Mar 20247:00 amRNS2023 Annual Dividend Declaration
5th Mar 20247:00 amRNSNotice of AGM
5th Mar 20247:00 amRNS2023 Annual Report and Accounts
5th Mar 20247:00 amRNS2023 Final Results
1st Mar 20242:00 pmRNSRetirement of Chris Ambler from the Board
28th Feb 20247:00 amRNSApax Funds Acquire IES
8th Feb 20247:00 amRNSEstimated Adjusted NAV as at 31 December 2023
2nd Feb 20247:00 amRNSApax Funds Acquire WGSN
4th Dec 20233:00 pmEQSHardman & Co Q&A on Apax Global Alpha: Hidden gems strategy delivering new investment opportunities
23rd Nov 202312:43 pmEQSHardman & Co Research on Apax Global Alpha (APAX): “Hidden Gems” strategy: green shoots into live deals
17th Nov 202312:58 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSApax Funds Invest in Petvisor
9th Nov 20237:00 amRNSQuarterly Results to 30 September 2023
27th Oct 20237:00 amRNSApax Funds Acquire GAN Integrity
12th Oct 20232:15 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages
11th Oct 20237:00 amRNSApax Funds acquire Bazooka Candy Brands
5th Oct 20237:00 amRNSNotice of Q3 2023 Financial Results
2nd Oct 20237:00 amRNSDirectorate Change
25th Sep 20235:06 pmRNSHolding in Company
25th Sep 20232:45 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Resilience in face of rising interest rates
12th Sep 202311:30 amRNSDirector/PDMR Shareholding
6th Sep 20237:02 amRNS2023 Interim Dividend
6th Sep 20237:01 amRNS2023 Interim Report and Accounts
6th Sep 20237:00 amRNS2023 Interim Results Highlights
7th Aug 20237:00 amRNSEstimated Adjusted NAV as at 30 June 2023
1st Aug 20237:00 amRNSFunds advised by Apax to acquire Palex
20th Jul 20234:35 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX) Capital Markets Day: value added by the manager
5th Jul 20233:50 pmEQSHardman & Co Research on Apax Global Alpha (APAX) 2023 Capital Markets Day: accessing hidden gems
2nd Jun 20237:00 amRNSFunds advised by Apax invest in Swing Education
23rd May 20237:00 amRNSNotice of Capital Markets Day
16th May 20237:00 amRNSFunds advised by Apax to acquire IBS Software
4th May 20237:00 amRNSResult of AGM
4th May 20237:00 amRNSQuarterly results for 31 March 2023
21st Mar 20232:05 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): 2022 results adding value to companies leads to outperformance
14th Mar 20232:05 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
13th Mar 20237:00 amRNSUpdate relating to SVB
2nd Mar 20237:00 amRNS2022 Annual Dividend Declaration
2nd Mar 20237:00 amRNSNotice of AGM
2nd Mar 20237:00 amRNS2022 Annual Report and Accounts
2nd Mar 20237:00 amRNS2022 Final Results
2nd Feb 20237:00 amRNSThe Apax Digital Fund II invests in Magaya
2nd Feb 20237:00 amRNSApax Funds’ Valuations and Credit Facility update
24th Jan 202310:15 amEQSHardman & Co Q&A on Apax Global Alpha (APAX): Adding value to private companies

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.